4.8 Review

Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Therapeutic Potential of TLR8 Agonist GS-9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators

Oliver E. Amin et al.

Summary: GS-9688 activates immune cell subsets and induces the production of immunomodulatory mediators in healthy controls and CHB patients. It boosts antiviral effector functions by activating HBV-specific CD8(+) T cells, CD4(+) follicular helper T cells, NK cells, and mucosal-associated invariant T cells. Additionally, GS-9688 modulates immunoregulatory subsets, potentially optimizing its antiviral efficacy.

HEPATOLOGY (2021)

Article Cell Biology

Hepatitis B virus particles activate B cells through the TLR2-MyD88-mTOR axis

Qian Li et al.

Summary: Host immune control is crucial in resolving primary hepatitis B virus (HBV) infections. This study found that TLR2 mRNA accumulation is most impacted during woodchuck hepatitis virus (WHV) infection resolution, with B-cell TLR2 activation playing a key role in HBV infection resolution.

CELL DEATH & DISEASE (2021)

Article Engineering, Biomedical

Delivery of toll-like receptor 3 ligand poly(I:C) to the liver by calcium phosphate nanoparticles conjugated with an F4/80 antibody exerts an anti-hepatitis B virus effect in a mouse model

Yanqin Du et al.

Summary: Nanoparticles carrying poly(I:C) conjugated with an F4/80 antibody showed enhanced liver targeting and significantly reduced HBV levels in mice, suggesting a promising alternative for future anti-HBV treatment.

ACTA BIOMATERIALIA (2021)

Article Immunology

Hepatitis B Surface Antigen Suppresses the Activation of Nuclear Factor Kappa B Pathway via Interaction With the TAK1-TAB2 Complex

Feiyan Deng et al.

Summary: This study reveals a novel mechanism by which HBsAg interacts with the TAK1-TAB2 complex to suppress the activation of the NF-kappa B signaling pathway, facilitating HBV evasion from immune responses. Autophagic degradation of TAK1 and TAB2 by HBsAg is identified as a key process involved in this mechanism. These findings provide new insights into the pathogenesis of chronic hepatitis B.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

In Vivo Mouse Models for Hepatitis B Virus Infection and Their Application

Yanqin Du et al.

Summary: This review provides a comprehensive overview of the characteristics and limitations of various mouse models used in HBV research, aiming to guide future studies in this field.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming

Giorgia De Simone et al.

Summary: The study identified a subset of KCs, referred to as KC2, that can cross-present hepatocellular antigens under IL-2 administration to improve T cell antiviral function. By sensing IL-2 and presenting antigens, KC2 can overcome the tolerogenic potential of the hepatic microenvironment, suggesting new strategies for enhancing hepatic T cell immunity.

IMMUNITY (2021)

Article Immunology

Influence of Pattern Recognition Receptor Ligands on Induction of Innate Immunity and Control of Hepatitis B Virus Infection

Sahar Asadi-Asadabad et al.

Summary: The study revealed that different pattern recognition receptor agonists have varying effects on inhibiting chronic hepatitis B, with Poly(I:C)-HMW and Poly(I:C)-HMW/LyoVec showing significant inhibitory effects on HBV, while others did not show significant effects.

VIRAL IMMUNOLOGY (2021)

Article Immunology

Follicular Helper T (T-FH) Cell Targeting by TLR8 Signaling For Improving HBsAg-Specific B Cell Response In Chronic Hepatitis B Patients

Natarajan Ayithan et al.

Summary: TLR8 activation enhances follicular helper T cell function, leading to improved B cell response in chronic hepatitis B infection. TLR8 agonists may promote monocyte-mediated T-FH function and enhance HBV-specific B cell responses, potentially playing a role in achieving HBV functional cure.

FRONTIERS IN IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Toll-like Receptors and the Control of Immunity

Katherine A. Fitzgerald et al.

Article Gastroenterology & Hepatology

Characteristics of Impaired Dendritic Cell Function in Patients With Hepatitis B Virus Infection

Atsushi Yonejima et al.

HEPATOLOGY (2019)

Article Medical Laboratory Technology

TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection

I Sghaier et al.

BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2019)

Article Gastroenterology & Hepatology

Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver

Aleksei Suslov et al.

GASTROENTEROLOGY (2018)

Review Gastroenterology & Hepatology

Immunotherapy for Chronic Hepatitis B Virus Infection

Antonio Bertoletti et al.

GUT AND LIVER (2018)

Article Gastroenterology & Hepatology

Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B

Harry L. A. Janssen et al.

JOURNAL OF HEPATOLOGY (2018)

Article Multidisciplinary Sciences

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes

Julie Lucifora et al.

SCIENTIFIC REPORTS (2018)

Article Public, Environmental & Occupational Health

Access to Treatment for Hepatitis B Virus Infection — Worldwide, 2016

Yvan Hutin et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)

Article Medicine, Research & Experimental

PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection

Loghman Salimzadeh et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Review Medicine, Research & Experimental

Kupffer cells in immune activation and tolerance toward HBV/HCV infection

Fangchao Yuan et al.

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2017)

Article Gastroenterology & Hepatology

Impaired expression and function of TLR8 in chronic HBV infection and its association with treatment responses during peg-IFN-α-2a antiviral therapy

Guangying Deng et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

Functionally aberrant dendritic cell subsets and expression of DC-SIGN differentiate acute from chronic HBV infection

Sukriti Sukriti et al.

HEPATOLOGY INTERNATIONAL (2016)

Review Gastroenterology & Hepatology

Adaptive immunity in HBV infection

Antonio Bertoletti et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection

Edward J. Gane et al.

JOURNAL OF HEPATOLOGY (2015)

Review Immunology

The role of hepatic immune regulation in systemic immunity to viral infection

Percy A. Knolle et al.

MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)

Review Gastroenterology & Hepatology

IL-6 Plays a Crucial Role in HBV Infection

Tian Lan et al.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2015)

Article Immunology

Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion

Dimitra Peppa et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2013)

Article Virology

Pattern recognition receptor responses in children with chronic hepatitis B virus infection

Ida Louise Heiberg et al.

JOURNAL OF CLINICAL VIROLOGY (2012)

Article Gastroenterology & Hepatology

Mechanisms Balancing Tolerance and Immunity in the Liver

Jan P. Boettcher et al.

DIGESTIVE DISEASES (2011)

Article Gastroenterology & Hepatology

Cross-Presentation of Antigen by Diverse Subsets of Murine Liver Cells

Mohammad R. Ebrahimkhani et al.

HEPATOLOGY (2011)

Article Multidisciplinary Sciences

Hepatitis B Virus Impairs TLR9 Expression and Function in Plasmacytoid Dendritic Cells

Isabelle E. Vincent et al.

PLOS ONE (2011)

Article Biochemistry & Molecular Biology

The divergence and interplay between pDC and mDC in humans

Norimitsu Kadowaki

FRONTIERS IN BIOSCIENCE-LANDMARK (2009)

Article Gastroenterology & Hepatology

Temporal Analysis of Early Immune Responses in Patients With Acute Hepatitis B Virus Infection

Claire Dunn et al.

GASTROENTEROLOGY (2009)

Article Gastroenterology & Hepatology

Not Interferon, but Interleukin-6 Controls Early Gene Expression in Hepatitis B Virus Infection

Marianna Hoesel et al.

HEPATOLOGY (2009)

Article Biochemistry & Molecular Biology

HBsAg inhibits TLR9-mediated activation and IFN-α production in plasmacytoid dendritic cells

Yongfen Xu et al.

MOLECULAR IMMUNOLOGY (2009)

Article Gastroenterology & Hepatology

Mechanism of T cell tolerance induction by murine hepatic Kupffer cells

Qiang You et al.

HEPATOLOGY (2008)

Article Immunology

Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor

Julie Tabiasco et al.

JOURNAL OF IMMUNOLOGY (2006)

Article Immunology

TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation

Anne Cottalorda et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2006)

Review Biochemistry & Molecular Biology

Pathogen recognition and innate immunity

S Akira et al.

Article Multidisciplinary Sciences

Genomic analysis of the host response to hepatitis B virus infection

S Wieland et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Multidisciplinary Sciences

TLR2 is expressed on activated T cells as a costimulatory receptor

M Komai-Koma et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Biochemistry & Molecular Biology

Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes

P Vanlandschoot et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)